Compliance with typical versus atypical antipsychotic medications

Drug Benefit Trends

Volumn 15, Issue 8, 2003, Pages

  Cooper, Amy E ^a   Hanrahan, Patricia ^a   Luchins, Daniel J ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Office of Mental Health   (United States)

Author keywords

Atypical antipsychotics; Medication compliance; Schizophrenia; Typical antipsychotics

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; PLACEBO; RISPERIDONE;

CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DATA BASE; DRUG COST; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MENTAL HEALTH; META ANALYSIS; PATIENT COMPLIANCE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; TARDIVE DYSKINESIA;

EID: 0041762032     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Olfson M, Mechanic D, Hansell S, et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000;51:216-222.
2. Wyatt RJ, Henter I, Leary MC, Taylor E. An economic evaluation of schizophrenia - 1991. Soc Psychiatry Psychiatr Epidemiol. 1995;30:196-205.
3. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry. 2002;63:892-909.
4. Van Putten T. Drug refusal in schizophrenia: Causes and prescribing hints. Hosp Community Psychiatry. 1978;29:110-112.
5. Wahlbeck K, Tuunainen A, Ahokas A, Leucht S. Dropout rates in randomised antipsychotic drug trials. Psychopharmacology (Berl). 2001;155:230-23.
6. Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis. BMJ. 2000;321:1371-1376.
7. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: Is there a difference between typical and atypical agents? Am J Psychiatry. 2002;159:103-108.
8. Vanelli M, Burstein P, Cramer J. Refill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chain. Psychiatr Serv. 2001;52:1248-1250.
9. Menzin J, Boulanger L, Friedman M, et al. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatr Serv. 2003;54:719-723.
10. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49:196-201.
11. Malan RD, Luchins DJ, Fichtner CG, et al. Discontinuity of outpatient antipsychotic pharmacotherapy: Risperidone maintenance after hospitalization. J Pharm Technol. 2001;17:90-94.
12. Ene-Stroescu V, Hanrahan P, Roberts DL, et al. Continuity of antipsychotic medications in transition from hospital to outpatient care. Presented at: 54th Meeting of the American Psychiatric Association's Institute of Psychiatric Services; October 9-13, 2002; Chicago.
13. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophr Bull. 1998;24:11-20.
14. Mental Health: A Report of the Surgeon General - Executive Summary. Rockville, Md: US Dept of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health, National Institute of Mental Health; 1999.